Get Patent Opposition Report for Galenicum

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Galenicum against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3090730Novel Pharmaceutical CompositionNOVARTISJan 9, 2025
EP2395968Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIMOct 16, 2024
EP3270909Fixed Dose Combinations Comprising Etc1002 And One Or More Statins For Treating Or Reducing Cardiovascular RiskESPERION THERAPEUTICSJul 31, 2024
EP3634463Improved Protocol For Treatment Of Lupus NephritisAURINIA PHARMACEUTICALSJun 27, 2024
EP3810201Gip/Glp1 Agonist CompositionsELI LILLYMar 7, 2024
EP2508188Pharmaceutical Formulations Containing Dapagliflozin Propylene Glycol HydrateASTRAZENECAFeb 9, 2024
EP2482812Therapeutic Uses Of Pharmaceutical CompositionsBOEHRINGER INGELHEIMOct 11, 2023
EP3191461Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-BenzoxazolePFIZERAug 3, 2022
EP2863895Tablet Formulation Comprising A Peptide And A Delivery AgentNOVO NORDISKJan 14, 2022
EP3431475Solid Forms Of A Selective Cdk4/6 InhibitorPFIZERJan 7, 2022

Explore Galenicum's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3512505Mar 15, 2023Vildagliptin Pharmaceutical Compositions4
EP3240529Feb 2, 2022Stable Pharmaceutical Compositions Comprising Micafungin4
EP2915526Jun 2, 2021Pharmaceutical Compositions Comprising Anagrelide2
EP3102187Mar 25, 2020Stable Pharmaceutical Compositions Containing Sitagliptin In The Form Of Immediate Release Tablets14